Ignite Creation Date:
2024-05-06 @ 7:37 PM
Last Modification Date:
2024-10-26 @ 3:10 PM
Study NCT ID:
NCT06079372
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2023-10-06
Brief Title:
Phase 3 Study of ALXN1850 in Pediatric Participants With HPP Previously Treated With Asfotase Alfa
Sponsor:
Alexion Pharmaceuticals Inc
Organization:
Alexion Pharmaceuticals Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-02
Start Date Type:
ACTUAL
Primary Completion Date:
2025-04-21
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-10-15
Completion Date Type:
ESTIMATED
First Submit Date:
2023-10-06
First Submit QC Date:
October 6 2023
Study First Post Date:
2023-10-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-10
Last Update Post Date:
2024-07-03
Last Update Post Date Type:
ACTUAL